Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (201-210 of 527) with videos related to

Pageof 53
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2013
No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibodyMatthias Preusser, Anna S Berghoff, David Capper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 24, 2012
Expression of BRAF V600E mutant protein in epithelial ovarian tumorsMatthias Preusser, David Capper, Anna S Berghoff, et al.
Clinical & Experimental Metastasis|July 25, 2016
Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancerThomas Schweiger, Anna Sophie Berghoff, Christoph Glogner, et al.
Anti-Cancer Drugs|January 21, 2014
Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution studyMarco R Hassler, Michael Ackerl, Birgit Flechl, et al.
Neuro-Oncology|March 21, 2022
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastomaEmilie Le Rhun, Felix Boakye Oppong, Maureen Vanlancker, et al.
Anticancer Research|March 14, 2013
Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinomaUrsula Pluschnig, Sebastian F Schoppmann, Matthias Preusser, et al.
Acta Neuropathologica|October 8, 2014
Predictive molecular markers in metastases to the central nervous system: recent advances and future avenuesAnna Sophie Berghoff, Rupert Bartsch, Adelheid Wöhrer, et al.
Plos One|November 9, 2013
5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancementGeorg Widhalm, Barbara Kiesel, Adelheid Woehrer, et al.
Oncotarget|February 23, 2018
The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junctionGerd Jomrich, Marlene Hollenstein, Maximilian John, et al.
Acta Neuropathologica|December 23, 2004
Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survivalMatthias Preusser, Stefan Wolfsberger, Christine Haberler, et al.
Pageof 53

Showing results (201-210 of 527) with videos related to

Sort By:
Pageof 53
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2013
No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibodyMatthias Preusser, Anna S Berghoff, David Capper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 24, 2012
Expression of BRAF V600E mutant protein in epithelial ovarian tumorsMatthias Preusser, David Capper, Anna S Berghoff, et al.
Clinical & Experimental Metastasis|July 25, 2016
Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancerThomas Schweiger, Anna Sophie Berghoff, Christoph Glogner, et al.
Anti-Cancer Drugs|January 21, 2014
Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution studyMarco R Hassler, Michael Ackerl, Birgit Flechl, et al.
Neuro-Oncology|March 21, 2022
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastomaEmilie Le Rhun, Felix Boakye Oppong, Maureen Vanlancker, et al.
Anticancer Research|March 14, 2013
Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinomaUrsula Pluschnig, Sebastian F Schoppmann, Matthias Preusser, et al.
Acta Neuropathologica|October 8, 2014
Predictive molecular markers in metastases to the central nervous system: recent advances and future avenuesAnna Sophie Berghoff, Rupert Bartsch, Adelheid Wöhrer, et al.
Plos One|November 9, 2013
5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancementGeorg Widhalm, Barbara Kiesel, Adelheid Woehrer, et al.
Oncotarget|February 23, 2018
The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junctionGerd Jomrich, Marlene Hollenstein, Maximilian John, et al.
Acta Neuropathologica|December 23, 2004
Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survivalMatthias Preusser, Stefan Wolfsberger, Christine Haberler, et al.
Pageof 53